A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of VARIVAX Made With the Varicella Enhanced Process (VEP)
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 30 Jan 2015
At a glance
- Drugs Varicella zoster virus vaccine live (Primary) ; Measles mumps and rubella virus vaccine
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics
- Sponsors Merck Sharp & Dohme
- 26 Jan 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 01 Mar 2013 Planned end date changed from 1 May 2014 to 1 Oct 2015 as reported by ClinicalTrials.gov.
- 01 Mar 2013 Planned initiation date changed from 1 Jun 2013 to 1 Jul 2014 as reported by ClinicalTrials.gov.